GSK logo

GSK Total Costs & Expenses

Latest reported£26.33B GBP
GSK TTM Total Costs & Expenses · GBP (£1.43B → £26.33B)
High-resolution chart · PNG

GSK total costs & expenses history

Trailing twelve months (TTM) · GBP. Each value covers four complete reported quarters.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) Total Costs & Expenses — Trailing twelve months (TTM) (GBP)
Period endingTotal Costs & Expenses (GBP)
26,330,000,000
24,365,000,000
24,329,000,000
24,638,000,000
26,507,000,000
26,782,000,000
27,355,000,000
27,413,000,000
25,788,000,000
24,587,000,000
23,583,000,000
21,612,000,000
22,052,000,000
22,863,000,000
22,891,000,000
26,015,000,000
24,624,000,000
23,339,000,000
24,167,000,000
23,213,000,000
24,754,000,000
24,965,000,000
26,316,000,000
25,635,000,000
26,085,000,000
27,636,000,000
26,793,000,000
26,439,000,000
25,383,000,000
25,589,000,000
25,338,000,000
25,822,000,000
25,606,000,000
26,415,000,000
26,099,000,000
25,963,000,000
26,108,000,000
25,451,000,000
25,291,000,000
24,840,000,000
23,831,000,000
22,701,000,000
13,601,000,000
12,556,000,000
12,397,000,000
11,268,000,000
19,409,000,000
18,379,000,000
18,377,000,000
19,133,000,000
19,477,000,000
19,874,000,000
19,804,000,000
19,373,000,000
19,108,000,000
19,345,000,000
19,463,000,000
19,656,000,000
19,580,000,000
21,998,000,000
21,864,000,000
23,896,000,000
24,609,000,000
22,739,000,000
22,571,000,000
20,149,000,000
19,943,000,000
19,624,000,000
19,162,000,000
18,545,000,000
17,211,000,000
15,945,737,500
17,144,084,450
16,954,084,450
16,657,084,450
16,848,176,900
15,043,829,950
15,200,737,750
15,409,735,870
21,935,283,920
22,004,283,920
21,632,686,120
21,286,688,000
14,474,677,760
14,214,777,100
14,130,467,100
14,203,467,100
14,442,939,340
14,810,840,000
14,814,514,240
15,029,840,000
15,142,000,000
15,239,000,000
15,563,325,760
15,661,000,000
14,302,806,640
14,404,806,640
14,396,806,640
14,430,806,640
15,227,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.